Lorbrexen 100 mg (Lorlatinib), generic Lorbrena is a prescription medicine used to treat metastatic non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. It is used in patients who have already received alectinib, ceritinib, or both crizotinib and at least 1 other medicine to treat NSCLC that is caused by the…
Olanib is used for the returning treatment of some types of ovarian cancer in patients who have had platinum chemotherapy or a change in a gene called BRCA. Olanib is a potent oral poly(ADP-ribose) polymerase (PARP) inhibitor. Cancer cells rely on PARP to stay alive, including cancer cells whose BRCA gene changes, thus Olanib works to stop PARP from repairing…
Osimertinib is kinase inhibitor of the epidermal growth factor receptor (EGFR), which binds irreversibly to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion) at approximately 9-fold lower concentrations than wild-type. In cultured cells and animal tumor implantation models, osimertinib exhibited anti-tumor activity against non-small cell lung cancer (NSCLC) lines harboring EGFR-mutations (T790M/L858R, L858R, T790M/exon 19 deletion, and…
Osimert 80 mg is the Bangladeshi version of osimertinib. It is formulated with the original formula. Original tagrisso and Bangladesh made Osimert work the same. Also Osimert 80mg Low price, provider & seller company.
Ponatinix (Ponatinib), generic Iclusig is a prescription medicine used to treat a type of blood cancer which is chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) for whom no other tyrosine kinase inhibitor (TKI) medicines are received. Ponatinix manufactured by Beacon Pharma Ltd. in Bangladesh.
Sotoxen 120 Mg (Sotorasib) is used to treat a certain type of lung cancer (non-small cell lung cancer; NSCLC) that has spread to other parts of the body or cannot be removed by surgery in adults who have received at least one other treatment. Sotorasib is in a class of medications called KRAS inhibitors. It works by blocking the action…
Tagrix is the 1st global generic of osimertinib. This drug is a third generation EGFR inhibitor. Osimertinib (Tagrix) is the 1st and only drug of its kind approved by USFDA for the treatment of epidermal growth factor receptor (EGFR) positive Non- Small Cell Lung Cancer (NSCLC) patient with T790M mutation.